Akso Health Group - ROE
HX
Price:
$2.24
Market Cap:
$1.17B
Hexindai Inc. operates as a holding company, overseeing an online platform that effectively links individuals in search of loans with potential investors. Based in Beijing, China, the firm maintains a workforce of 552 full-time employees. For its borrower clientele, the company's primary focus is to deliver a diverse range of financial products. These offerings are carefully crafted using customer segmentation data, ensuring they are precisely tailored to the distinct requirements of China's growing middle-income demographic. Among its specialized services, the company provides five distinct loan categories: Provident Fund Loans, Property-Owner Loans, Car-Owner Loans, Insurance-Holder Loans,...[Read more]
Industry
Medical - Distribution
IPO Date
2017-11-03
Stock Exchange
NASDAQ
Ticker
HX
PE Ratio
[-1.84]
ROE
[-15.00%]
Current Ratio
[21.77]
Dividend Yield
[0%]
Enterprise Value
[1.17B]
Dividend History
The ROE as of October 2026 (TTM) for Akso Health Group (HX) is -15.00%
According to Akso Health Group’s latest financial reports and current stock price. The company's current ROE is -15.00%. This represents a change of 21.96% compared to the average of -12.30% of the last 4 quarters.
Akso Health Group (HX) Historical ROE (quarterly & annually)
How has HX ROE performed in the past?
The mean historical ROE of Akso Health Group over the last ten years is -49.98%. The current -15.00% ROE has changed -69.99% with respect to the historical average. Over the past ten years (40 quarters), HX's ROE was at its highest in in the March 2020 quarter at 136.22%. The ROE was at its lowest in in the March 2021 quarter at -116.47%.
Average
-49.98%
Median
-12.95%
Minimum
-201.64%
Maximum
46.76%
Akso Health Group (HX) ROE by Quarter and Year
Discovering the peaks and valleys of Akso Health Group ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 891.62%
Maximum Annual ROE = 46.76%
Minimum Annual Increase = -3484.47%
Minimum Annual ROE = -201.64%
| Year | ROE | Change |
|---|---|---|
| 2026 | -10.32% | -84.78% |
| 2025 | -67.79% | 891.62% |
| 2024 | -6.84% | -56.14% |
| 2023 | -15.59% | -88.64% |
| 2022 | -137.17% | -31.97% |
| 2021 | -201.64% | 36.23% |
| 2020 | -148.02% | -3484.47% |
| 2019 | 4.37% | -90.65% |
| 2018 | 46.76% | 28.23% |
| 2017 | 36.47% | 44.40% |
Akso Health Group (HX) Average ROE
How has HX ROE performed in the past?
The current ROE of Akso Health Group (HX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.31%
5-year avg
-47.54%
10-year avg
-49.98%
Akso Health Group (HX) ROE vs. Peers
How is HX’s ROE compared to its peers?
Akso Health Group’s ROE is greater than Eargo, Inc. (-185.26%), greater than Kronos Bio, Inc. (-69.80%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than Singular Genomics Systems, Inc. (-43.17%), greater than Bonk, Inc. (-196.39%), greater than AlloVir, Inc. (-71.71%), less than Heat Biologics, Inc. (26.55%), greater than AlerisLife Inc. (-15.17%), less than NeueHealth, Inc. (34.61%), greater than TCR2 Therapeutics Inc. (-71.90%),
| Company | ROE | Market cap |
|---|---|---|
| -185.26% | $53.36M | |
| -69.80% | $53.65M | |
| -74.73% | $56.22M | |
| -43.17% | $50.77M | |
| -196.39% | $9.76M | |
| -71.71% | $49.48M | |
| 26.55% | $61.07M | |
| -15.17% | $44.18M | |
| 34.61% | $60.94M | |
| -71.90% | $58.11M |
Build a custom stock screener for Akso Health Group (HX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akso Health Group using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Akso Health Group (HX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Akso Health Group or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Akso Health Group's ROE?
How is the ROE calculated for Akso Health Group (HX)?
What is the highest ROE for Akso Health Group (HX)?
What is the 3-year average ROE for Akso Health Group (HX)?
What is the 5-year average ROE for Akso Health Group (HX)?
How does the current ROE for Akso Health Group (HX) compare to its historical average?